SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Hypha Labs, Inc. (FUNI) (CIK 0001502966) (FUNI) — Mar 13, 2014

Hypha Labs, Inc. (FUNI) (CIK 0001502966)
Date: March 13, 2014 · CIK: 0001502966 · Accession: 0000000000-14-012758

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-54239

Date
March 13, 2014
Author
/s/ Tom Kluck
Form
UPLOAD
Company
Hypha Labs, Inc. (FUNI) (CIK 0001502966)

Letter

March 13, 2014 Via E -mail Eric Stoppenhagen President and Chief Financial Officer DigiP ath, Inc. 1328 W. Balboa Blvd., Suite C Newport Beach, CA 92661

Re: DigiPath, Inc. Preliminary Information Statement on Schedule 14 C Filed March 3, 2014 File No. 000-54239

Dear Mr. Stoppenhagen :

We have limited our review of your filing to the issues we have addressed in our comments . In some of our comments, we may ask you to provide us with information so we may better understand your disclosure.

Please respond to this letter within ten business days by amending your filing, by providing the requested information, or by advising us when you will provide the requested response. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your filing and the information you provide in response to these comments, we may have additional comments.

General

1. Please explain your basis for incorporating certain information by reference into your information statement. Please refer to Note D to Schedule 14A.

2. Please revise your discussion of the proposal to in crease the number of authorized shares of preferred stock to indicate the purpose of the authorization of these securities or advise. Please refer to Item 11(c) of Schedule 14A.

We urge all persons who are responsible for the accuracy and adequacy of th e disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable Exchange Act rules require. Since the company and its management are in possession of all facts relating to a company’ s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.

Eric Stoppenhagen DigiPath, Inc. March 13, 2014 Page 2

In responding to our comments, please provide a written statement from the company acknowledging that:

 the company is responsible for the adequacy and accuracy of the disclosure in the filing;

 staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

 the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please contact Beth Frohlichstein at (202) 551-3789 or me at (202) 551-3233 with any questions.

Sincerely,
/s/ Tom Kluck

Show Raw Text
March 13, 2014

Via E -mail
Eric Stoppenhagen
President and Chief Financial Officer
DigiP ath, Inc.
1328 W. Balboa Blvd., Suite C
Newport Beach, CA 92661

Re: DigiPath, Inc.
 Preliminary Information  Statement on Schedule 14 C
Filed March 3, 2014
File No. 000-54239

Dear Mr. Stoppenhagen :

We have limited our review of your filing to the issues we have addressed in our
comments .  In some of our comments, we may ask you to provide  us with information so we
may better understand your disclosure.

Please respond to this letter within ten business days by amending your filing, by
providing the requested information, or by advising us when you will provide the requested
response.   If you do not believe our comments apply to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your filing and the information you provide in
response to these  comments, we may have  additional comments.

General

1. Please explain your basis for incorporating certain information by reference into your
information statement.   Please refer to Note D to Schedule 14A.

2. Please revise your discussion of the proposal to in crease the number of authorized shares
of preferred stock to indicate the purpose of the authorization of these securities or
advise.  Please refer to Item 11(c) of Schedule 14A.

We urge all persons who are responsible for the accuracy and adequacy of th e disclosure
in the filing to be certain that the filing includes the information the Securities Exchange Act of
1934 and all applicable Exchange Act rules require.   Since the company and its management are
in possession of all facts relating to a company’ s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.

Eric Stoppenhagen
DigiPath, Inc.
March 13, 2014
Page 2

 In responding to our comments, please provide  a written statement from the company
acknowledging that:

 the company is responsible for the adequacy and accuracy of the disclosure in the filing;

 staff comments or changes to disclosure in response to staff comments do not foreclose
the Commission from taking any action with respect to the filing; and

 the company may not assert staff comments as a defense in any proceeding initiated by
the Commission or any person under the federal securities laws of the United States.

Please contact Beth Frohlichstein  at (202) 551-3789  or me at  (202) 551-3233 with any
questions.

Sincerely,

 /s/ Tom Kluck

Tom Kluck
Legal Branch Chief